Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cholera].

Jean-Michel Fournier1, Marie-Laure Quilici

  • 1Unité du Choléra et des Vibrions, Centre National de Référence des Vibrions et du Choléra, Institut Pasteur, Paris. vibrions@pasteur.fr

Presse Medicale (Paris, France : 1983)
|March 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Long-distance spread of a highly drug-resistant cholera strain].

Medecine sciences : M/S·2025
Same author

Recent and convergent reversion to serotype Ogawa in the AFR12 sublineage of <i>Vibrio cholerae</i> O1 El Tor in Cameroon.

Microbial genomics·2025
Same author

Genomic analysis of <i>Vibrio cholerae</i> O1 isolates from cholera cases, Europe, 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

<i>Vibrio cholerae</i> serogroup O5 was responsible for the outbreak of gastroenteritis in Czechoslovakia in 1965.

Microbial genomics·2024
Same author

An unusual two-strain cholera outbreak in Lebanon, 2022-2023: a genomic epidemiology study.

Nature communications·2024
Same author

Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019.

Diagnostic microbiology and infectious disease·2024

Cholera, a severe intestinal infection, causes thousands of deaths annually. A new rapid diagnostic test and improved vaccines are crucial for controlling this pandemic disease, especially in areas with poor sanitation.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Cholera is a significant global health threat, causing pandemics with high mortality rates.
  • Official case and death counts are likely underestimated due to surveillance limitations.
  • The disease is caused by Vibrio cholerae and thrives in environments with poor sanitation and hygiene.

Purpose:

  • To highlight the challenges in cholera diagnosis and control.
  • To introduce a new rapid diagnostic test developed by the Pasteur Institute.
  • To discuss the current status and limitations of cholera vaccines.

Summary:

  • Cholera outbreaks are linked to poverty and inadequate sanitation, necessitating effective control measures.
  • Rehydration therapy and antibiotics significantly reduce cholera mortality.

Related Experiment Videos

  • A new one-step immunochromatographic rapid diagnostic test is nearing commercial availability.
  • Existing oral cholera vaccines offer short-term protection, but long-term vaccines for all age groups are still needed.

    • Impact:

    • The rapid diagnostic test aims to improve cholera outbreak response in resource-limited settings.
    • Enhanced diagnostic capabilities can facilitate timely treatment and epidemic containment.
    • Development of long-term cholera vaccines is essential for sustained global health security.